天弘国证生物医药ETF(159859)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2023/9/30 |
6,275,240,000 |
6,872,840,000 |
2,500,200,000 |
1,902,600,000 |
597,600,000 |
9.52% |
| 2023/6/30 |
2,491,640,000 |
6,275,240,000 |
5,196,600,000 |
1,413,000,000 |
3,783,600,000 |
151.85% |
| 2023/6/30 |
3,287,240,000 |
6,275,240,000 |
3,781,800,000 |
793,800,000 |
2,988,000,000 |
90.9% |
| 2023/3/31 |
2,491,640,000 |
3,287,240,000 |
1,414,800,000 |
619,200,000 |
795,600,000 |
31.93% |
| 2022/12/31 |
1,469,240,000 |
2,491,640,000 |
2,638,800,000 |
1,616,400,000 |
1,022,400,000 |
69.59% |
| 2022/12/31 |
2,671,640,000 |
2,491,640,000 |
703,800,000 |
883,800,000 |
-180,000,000 |
-6.74% |
| 2022/9/30 |
1,753,640,000 |
2,671,640,000 |
1,112,400,000 |
194,400,000 |
918,000,000 |
52.35% |
| 2022/6/30 |
1,469,240,000 |
1,753,640,000 |
822,600,000 |
538,200,000 |
284,400,000 |
19.36% |
| 2022/6/30 |
1,501,640,000 |
1,753,640,000 |
509,400,000 |
257,400,000 |
252,000,000 |
16.78% |
| 2022/3/31 |
1,469,240,000 |
1,501,640,000 |
313,200,000 |
280,800,000 |
32,400,000 |
2.21% |
| 2021/12/31 |
229,040,000 |
1,469,240,000 |
1,540,800,000 |
300,600,000 |
1,240,200,000 |
541.48% |
| 2021/12/31 |
158,840,000 |
1,469,240,000 |
1,422,000,000 |
111,600,000 |
1,310,400,000 |
824.98% |
| 2021/9/30 |
229,040,000 |
158,840,000 |
118,800,000 |
189,000,000 |
-70,200,000 |
-30.65% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
